Inventor · disambiguated record
Ralph A. Heasley
Also filed as: HEASLEY RALPH A
20 granted patents·21 pending applications·212 citations·filing 1980–2017
96Inventor score
Files withMALLINCKRODT LLC12MOORE KEITH A7XANODYNE PHARMACEUTICALS INC7XANODYNE PHARMACAL INC5DEVARAKONDA KRISHNA4
Top patents by PatentIndex Score
41 records- 0196US8858963B1Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesiaDEVARAKONDA KRISHNA·Filed 2012·Granted Oct 14, 2014·43 cites·22 claims
- 0295US8658631B1Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesiaDEVARAKONDA KRISHNA·Filed 2012·Granted Feb 25, 2014·22 cites·30 claims
- 0394US8992975B2Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesiaMALLINCKRODT LLC·Filed 2013·Granted Mar 31, 2015·10 cites·30 claims
- 0493US9050335B1Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesiaDEVARAKONDA KRISHNA·Filed 2012·Granted Jun 9, 2015·10 cites·31 claims
- 0593US8957113B2Tranexamic acid formulationsMOORE KEITH A·Filed 2011·Granted Feb 17, 2015·11 cites·30 claims
- 0693US8790694B2Gastric retentive extended release pharmaceutical compositionsMALLINCKRODT LLC·Filed 2013·Granted Jul 29, 2014·11 cites·30 claims
- 0793US8741885B1Gastric retentive extended release pharmaceutical compositionsDEVARAKONDA KRISHNA·Filed 2012·Granted Jun 3, 2014·12 cites·30 claims
- 0892US8022106B2Tranexamic acid formulationsFERRING BV·Filed 2009·Granted Sep 20, 2011·12 cites·57 claims
- 0991US9433582B2Gastric retentive extended release pharmaceutical compositionsMALLINCKRODT LLC·Filed 2014·Granted Sep 6, 2016·7 cites·30 claims
- 1091US8487005B2Tranexamic acid formulationsMOORE KEITH A·Filed 2012·Granted Jul 16, 2013·12 cites·41 claims
- 1191US8273795B2Tranexamic acid formulationsMOORE KEITH A·Filed 2008·Granted Sep 25, 2012·14 cites·12 claims
- 1290US7947739B2Tranexamic acid formulationsFERRING BV·Filed 2010·Granted May 24, 2011·14 cites·19 claims
- 1389US9629837B2Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesiaMALLINCKRODT LLC·Filed 2015·Granted Apr 25, 2017·3 cites·20 claims
- 1488US8809394B2Tranexamic acid formulationsMOORE KEITH A·Filed 2012·Granted Aug 19, 2014·9 cites·41 claims
- 1588US8791160B2Tranexamic acid formulationsMOORE KEITH A·Filed 2012·Granted Jul 29, 2014·9 cites·80 claims
- 1682US9060939B2Tranexamic acid formulationsMOORE KEITH A·Filed 2011·Granted Jun 23, 2015·5 cites·34 claims
- 1781US8968777B2Tranexamic acid formulations with reduced adverse effectsHEASLEY RALPH A·Filed 2006·Granted Mar 3, 2015·3 cites·18 claims
- 1879US9539328B2Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesiaMALLINCKRODT LLC·Filed 2014·Granted Jan 10, 2017·1 cites·27 claims
- 1972US2009215898A1Tranexamic acid formulationsXANODYNE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2071US2009017114A1Tranexamic acid formulations with reduced adverse effectsXANODYNE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2167US2008280981A1Tranexamic acid formulationsXANODYNE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2267US2017182033A1Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesiaMALLINCKRODT LLC·Filed 2017·Application pending·0 cites
- 2365US2016184299A1Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesiaMALLINCKRODT LLC·Filed 2016·Application pending·0 cites
- 2464US9468636B2Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesiaMALLINCKRODT LLC·Filed 2015·Granted Oct 18, 2016·0 cites·28 claims
- 2564US2015018419A1Tranexamic acid formulationsMOORE KEITH A·Filed 2014·Application pending·0 cites
- 2662US2016243041A1Gastric retentive extended release pharmaceutical compositionsMALLINCKRODT LLC·Filed 2016·Application pending·0 cites
- 2761US2005025825A1Tranexamic acid formulations with reduced adverse effectsXANODYNE PHARMACAL INC·Filed 2003·Application pending·0 cites
- 2861US2009214644A1Tranexamic acid formulations with reduced adverse effectsXANODYNE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2960US2017095470A1Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of AnalgesiaMALLINCKRODT LLC·Filed 2016·Application pending·0 cites
- 3057US2005244495A1Tranexamic acid formulationsXANODYNE PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3156US2015290157A1Tranexamic acid formulationsFERRING BV·Filed 2015·Application pending·0 cites
- 3253US2005080076A1N-desmethyl levomepromazineXANODYNE PHARMACAL INC·Filed 2003·Application pending·0 cites
- 3352US2014288113A1Extended Release Compositions Comprising Hydrocodone And Acetaminophen For Rapid Onset And Prolonged Analgesia That May Be Administered Without Regard To FoodMALLINCKRODT LLC·Filed 2014·Application pending·0 cites
- 3449US2003194374A1Compositions including a visual marker and method of use thereofXANODYNE PHARMACAL INC·Filed 2003·Application pending·0 cites
- 3548US2005245614A1Tranexamic acid formulationsXANODYNE PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3647US2015290127A1Tranexamic acid formulationsFERRING BV·Filed 2015·Application pending·0 cites
- 3746US2005176650A1Stable parenteral formulation of levomepromazine and a method for stabilizing said formulationXANODYNE PHARMACAL INC·Filed 2004·Application pending·0 cites
- 3844US2014275143A1Compositions Comprising An Opioid And An Additional Active Pharmaceutical Ingredient For Rapid Onset And Extended Duration Of Analgesia That May Be Administered Without Regard To FoodMALLINCKRODT LLC·Filed 2014·Application pending·0 cites
- 3941US2004180915A1Methadone-containing compositions for parenteral administration and method of use thereofXANODYNE PHARMACAL INC·Filed 2003·Application pending·0 cites
- 4039US2010280117A1Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding DisordersXANODYNE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4137US4338311AHydrophilic choline salicylate formulationRIKER LABORATORIES INC·Filed 1980·Granted Jul 6, 1982·4 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →